We are live on
!
Find out more
CI
Clal Insurance Portfolio holdings
AUM
$16.6B
1-Year Est. Return
68.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.29%
1 Year Est. Return
+68.34%
3 Year Est. Return
+151.82%
5 Year Est. Return
+175.48%
10 Year Est. Return
+729.64%
AUM
$8.37B
AUM Growth
+$1.69B
(+25%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
15.69%
Top 10 Holdings %
Top 10 Hldgs %
45.78%
Holding
159
New
14
Increased
30
Reduced
35
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$1.03B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$188M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$104M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$81.6M |
| 5 |
Invesco NASDAQ 100 ETF
QQQM
|
+$69.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$147M |
| 2 |
Nutrien
NTR
|
+$147M |
| 3 |
Check Point Software Technologies
CHKP
|
+$89M |
| 4 |
Franklin FTSE Brazil ETF
FLBR
|
+$74.9M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$52.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Industrials | 7.5% |
| 3 | Communication Services | 7.04% |
| 4 | Healthcare | 6.99% |
| 5 | Utilities | 4.41% |
Similar funds
AIMCA
EIP
IG
BCIM
UCFA
VMPIC
LCOV
Clal Insurance's Q2 2023 Portfolio in Review
As of Q2 2023, Clal Insurance held 159 positions worth $8.37B, up 25% from $6.68B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Clal Insurance deployed $1.31B of net new capital in Q2 2023, opening 14 new positions and adding to 30 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 7,154,000 shares worth $1.07B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Industrials and Communication Services.
On the sell side, the largest reduction was Nutrien, an estimated $147M trimmed.
- Clal Insurance's largest Q2 2023 buy was Invesco S&P 500 Equal Weight ETF: 7,154,000 shares worth $1.07B.
- Clal Insurance added most to Teva Pharmaceuticals in Q2 2023, an estimated $104M increase.
- Clal Insurance's biggest Q2 2023 reduction was Nutrien, cutting an estimated $147M.
- Clal Insurance fully exited State Street Consumer Staples Select Sector SPDR ETF in Q2 2023, selling an estimated $147M.
- Clal Insurance's ten largest holdings make up 46% of its $8.37B portfolio in Q2 2023.
- Clal Insurance opened 14 new positions and closed 11 in Q2 2023.
- Clal Insurance's portfolio value rose 25% quarter-over-quarter to $8.37B.
Based on Clal Insurance's 13F filing for Q2 2023, filed 7 Aug 2023.